Cargando…

Efficacy of low dose temozolomide in combination with bortezomib in U87 glioma cells: a flow cytometric analysis

INTRODUCTION: Maximizing responses of malignant gliomas is hampered by resistance to temozolomide (TMZ). Increasing efficacy but not toxicity is a key issue when testing drug combinations. The antimyeloma agent bortezomib (BZ) has shown promising results in vitro and is currently being tested in gli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vlachostergios, Panagiotis J., Papandreou, Christos N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2013
Materias:	Basic Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424237/ https://www.ncbi.nlm.nih.gov/pubmed/25995745 http://dx.doi.org/10.5114/aoms.2013.36919

Ejemplares similares

Microarray gene profiling analysis of glioblastoma cell line U87 reveals suppression of the FANCD2/Fanconi anemia pathway by the combination of Y15 and temozolomide
por: Wang, Zichuan, et al.
Publicado: (2019)

Diazepam diminishes temozolomide efficacy in the treatment of U87 glioblastoma cell line
por: Drljača, Jovana, et al.
Publicado: (2022)

The ubiquitin-proteasome system in glioma cell cycle control
por: Vlachostergios, Panagiotis J, et al.
Publicado: (2012)

MiR-181b suppresses proliferation of and reduces chemoresistance to temozolomide in U87 glioma stem cells()
por: Li, Ping, et al.
Publicado: (2010)

Investigation of platinum nanoparticle properties against U87 glioblastoma multiforme
por: Kutwin, Marta, et al.
Publicado: (2016)

The Effect of Temozolomide/Poly(lactide-co-glycolide) (PLGA)/Nano-Hydroxyapatite Microspheres on Glioma U87 Cells Behavior
por: Zhang, Dongyong, et al.
Publicado: (2012)

Differential pro-apoptotic effects of synthetic 4-thiazolidinone derivative Les-3288, doxorubicin and temozolomide in human glioma U251 cells
por: Коbylinska, Lesya I., et al.
Publicado: (2017)

Combination therapy of cold atmospheric plasma (CAP) with temozolomide in the treatment of U87MG glioblastoma cells
por: Gjika, Eda, et al.
Publicado: (2020)

Effect of eflornithine on mutation frequency in temozolomide-treated U87MG cells
por: Yam, Noymi, et al.
Publicado: (2020)

Role for Metallothionein-3 in the Resistance of Human U87 Glioblastoma Cells to Temozolomide
por: Santangelo, Rosa, et al.
Publicado: (2020)

Antitumor and apoptotic effects of 5-methoxypsoralen in U87MG human glioma cells and its effect on cell cycle, autophagy and PI3K/Akt signaling pathway
por: Guo, Haixia, et al.
Publicado: (2019)

Ceramide Is Involved in Temozolomide Resistance in Human Glioblastoma U87MG Overexpressing EGFR
por: Bassi, Rosaria, et al.
Publicado: (2023)

The Role of the Small Ubiquitin-Related Modifier (SUMO) Pathway in Prostate Cancer
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2012)

Targeting Neuroendocrine Prostate Cancer: Molecular and Clinical Perspectives
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2015)

Inhibition of autophagy enhances apoptosis induced by proteasome inhibitor bortezomib in human glioblastoma U87 and U251 cells
por: Zhang, Xudong, et al.
Publicado: (2013)

Propolis changes the anticancer activity of temozolomide in U87MG human glioblastoma cell line
por: Markiewicz-Żukowska, Renata, et al.
Publicado: (2013)

In Vitro Radiosensitizing Effects of Temozolomide on U87MG Cell Lines of Human Glioblastoma Multiforme
por: Borhani, Samira, et al.
Publicado: (2017)

Flow cytometric characterization of cell surface markers to differentiate between fibroblasts and mesenchymal stem cells of different origin
por: Sober, Suzanne A., et al.
Publicado: (2021)

Efficacy and Safety of Temozolomide Combined with Radiotherapy in the Treatment of Malignant Glioma
por: Wei, Shoufeng, et al.
Publicado: (2022)

Thymoquinone synergistically potentiates temozolomide cytotoxicity through the inhibition of autophagy in U87MG cell line
por: Pazhouhi, Mona, et al.
Publicado: (2016)

Temozolomide and tranilast synergistic antiproliferative effect on human glioblastoma multiforme cell line (U87MG)
por: Khazaei, Mozafar, et al.
Publicado: (2019)

Selecting for predisposition to cancer cachexia
por: Gioulbasanis, Ioannis, et al.
Publicado: (2012)

Metabolic Impact of Anti-Angiogenic Agents on U87 Glioma Cells
por: Mesti, Tanja, et al.
Publicado: (2014)

Retracted: Efficacy and Safety of Temozolomide Combined with Radiotherapy in the Treatment of Malignant Glioma
por: Engineering, Journal of Healthcare
Publicado: (2023)

Orbital Metastasis of Breast Carcinoma
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2009)

Basic Concepts in Metastatic Cardiac Disease
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2012)

Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1–Survivin axis
por: Tang, Jun-Hai, et al.
Publicado: (2019)

Resveratrol represses YKL-40 expression in human glioma U87 cells
por: Zhang, Wei, et al.
Publicado: (2010)

Single-Cell Mechanophenotyping in Microfluidics to Evaluate Behavior of U87 Glioma Cells
por: Sengul, Esra, et al.
Publicado: (2020)

Extended-schedule dose-dense temozolomide in refractory gliomas
por: Berrocal, A., et al.
Publicado: (2009)

Suppressing H19 Modulates Tumorigenicity and Stemness in U251 and U87MG Glioma Cells
por: Li, Weiguo, et al.
Publicado: (2016)

Early mRNA Expression of Neuroendocrine Differentiation Signals Predicts Recurrence After Radical Prostatectomy: A Transcriptomic Analysis
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2021)

XAF1 directs glioma response to temozolomide through apoptotic transition of autophagy by activation of ATM–AMPK signaling
por: Lee, Min-Goo, et al.
Publicado: (2022)

Inhibition of DNA Repair in Combination with Temozolomide or Dianhydrogalactiol Overcomes Temozolomide-Resistant Glioma Cells
por: Ohba, Shigeo, et al.
Publicado: (2021)

Temozolomide with Radiation Therapy in High Grade Brain Gliomas: Pharmaceuticals Considerations and Efficacy; A Review Article
por: Koukourakis, Georgios V., et al.
Publicado: (2009)

N-(2-hydroxyphenyl)acetamide (NA-2) and Temozolomide synergistically induce apoptosis in human glioblastoma cell line U87
por: Hanif, Farina, et al.
Publicado: (2014)

Caffeine Sensitizes U87-MG Human Glioblastoma Cells to Temozolomide through Mitotic Catastrophe by Impeding G2 Arrest
por: Li, Ning, et al.
Publicado: (2018)

Bmi-1 induces radioresistance by suppressing senescence in human U87 glioma cells
por: YE, LAN, et al.
Publicado: (2014)

Antitumor activity of tetrandrine citrate in human glioma U87 cells in vitro and in vivo
por: Sun, Jingyu, et al.
Publicado: (2019)

Quantifying Deformation and Migration Properties of U87 Glioma Cells Using Dielectrophoretic Forces
por: Elitas, Meltem, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vrk2sr6pmupibc56ddf2j1uu4b